Sharon Klahre | Vice President of Investor Relations and Strategic Finance |
Ankit Mahadevia | Chief Executive Officer |
David Melnick | Chief Medical Officer |
Cristina Larkin | Chief Operating Officer |
Steve DiPalma | Interim Chief Financial Officer |
Carvey Leung | Cantor |
Dushyanth Srinivasan | Cowen |
Ellen Sands | Stifel |
Operator Good day, and welcome to the Spero Therapeutics Third Quarter 2020 Financial Results Conference Call. Today's conference is being recorded. At this time, I'd like to turn the call over to Sharon Klahre, Vice President of Investor Relations and Strategic Finance. Please go ahead, ma'am.
Great.